“The market definitely has seen tremendous growth in Romania in ten years,” Lorenzovici Laszlo, pharmaceutical consultant and general manager of Hospital Consulting, told ZF.
His company estimates growth will continue because the government cannot leave the clawback tax in place indefinitely, he added, saying that Romania’s population of about 20 million people makes its pharmaceutical market impossible to ignore by pharmaceutical companies operating in the area.
ZF looked back on the trend of the revenue of the top ten pharmaceutical companies by drug sales in 2016, according to Cegedim data, over the past ten years. Cegedim data show the developments on the pharmaceutical market best, as the Finance Ministry data show lower figures and many big pharmaceutical companies operate under management consultancy, advertising agency and media representation NACE codes. Moreover only two of the top ten companies supplied 2016 financials at ZF’s request.
Abbvie, the market leader in 2016, posted RON1.4 billion sales, according to Cegedim (because of a hepatitis C drug) and did not supply information about 2016 sales to ZF. It posted RON301 million sales in 2015, according to Cegedim.
The data analyzed by ZF show that the revenue of the top three corporations in 2016 at least doubled over the past decade. The top five pharmaceutical companies boosted revenue by more than 50% in ten years, according to ZF’s calculations based on Cegedim data.
Astrazeneca tripled sales from RON107 million to RON410 million in 2007-2016. It ranked ninth in the Cegedim compiled ranking last year, while ten years ago it had not even entered the top ten. In 2008 it was already eighth with RON387 million revenue.
French-held Sanofi doubled revenue from RON399 million to RON831 million in 2007-2016.
Pfizer and Sevier are among the companies to have seen sales rise by at least 50% in in Romania. Swiss-held Novartis’ sales went up 48% in ten years, reaching RON591 million.
GlaxoSmithKline and Hoffman la Roche saw a slower growth, 15% in 2007-2016.
The total pharmaceutical market went up from RON6 billion to RON12.9 billion in the past decade, according to Cegedim data. (EUR1=RON4.5729)
(English version by Loredana Fratila-Cristescu)